Earlier this month, (June 2025), Novo inked a deal worth up to $815 million with Deep Apple Therapeutics, a South San Francisco-based company specializing in small-molecule drug discovery to discover, develop, and commercialize oral small-molecule therapeutics directed at a non-incretin G protein-coupled receptors (GPCR) target for cardiometabolic diseases, including obesity, in a deal worth up to $812 million
Some peptides may indirectly influence metabolism, which can impact thyroid balance
Proc Natl Acad Sci U S A (1997) 94:140605.10.1073/pnas.94.25.14060 33 MartinDLRimvallK
Mice with AhR deficiency in microglia, a macrophage population in the brain, develop more severe EAE, with increased expression of pro-inflammatory genes and loss of IL-10 and transforming growth factor- (TGF-) expression
If for any reason I have not made it clear, comment for further explanation
Not all labels are blue